The decline in demand for the pharmaceutical company Darnitsa's products could be due to the company's failure to lower sales prices after canceling marketing payments to pharmacies, as well as the price increase in late 2024 and early 2025, believes Yulia Klymeniuk, executive director of the Pharmacy 9-1-1 chain.